U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208264

Expand all

TEPADINA (THIOTEPA)
15MG/VIAL
Marketing Status: Prescription
Active Ingredient: THIOTEPA
Proprietary Name: TEPADINA
Dosage Form; Route of Administration: POWDER; INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Strength: 15MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N208264
Product Number: 001
Approval Date: Jan 26, 2017
Applicant Holder Full Name: ADIENNE SA
Marketing Status:  Prescription
Patent and Exclusivity Information
TEPADINA (THIOTEPA)
100MG/VIAL
Marketing Status: Prescription
Active Ingredient: THIOTEPA
Proprietary Name: TEPADINA
Dosage Form; Route of Administration: POWDER; INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Strength: 100MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N208264
Product Number: 002
Approval Date: Jan 26, 2017
Applicant Holder Full Name: ADIENNE SA
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top